Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study

Sarcopenia in nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality in the United States

(2021) Donghee Kim et al.   LIVER INTERNATIONAL

Korean frailty and aging cohort study (KFACS): cohort profile

(2020) Chang Won Won et al.   BMJ Open

Health Consequences of Sarcopenic Obesity: A Narrative Review

(2020) Eun Roh et al.   Frontiers in Endocrinology

Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey

(2020) Sunyoung Kang et al.   Journal of Cachexia Sarcopenia and Muscle

Sarcopenia: revised European consensus on definition and diagnosis

(2019) Alfonso J Cruz-Jentoft et al.   AGE AND AGEING

Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease

(2019) Da Gan et al.   CLINICAL NUTRITION

Sarcopenia and fatty liver disease

(2019) Jung A. Kim et al.   Hepatology International

Relationship between relative skeletal muscle mass and non-alcoholic fatty liver disease: A 7-year longitudinal study

(2018) Gyuri Kim et al.   HEPATOLOGY

Relative Handgrip Strength Is Inversely Associated with Metabolic Profile and Metabolic Disease in the General Population in China

(2018) Dongxue Li et al.   Frontiers in Physiology

Age-Related Decrease in Skeletal Muscle Mass Is An Independent Risk Factor for Incident NAFLD: A 10-Year Retrospective Cohort Study

(2018) Min Jung Lee et al.   Gut and Liver

Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance

(2017) Ruth C. R. Meex et al.   Nature Reviews Endocrinology

Comparisons of three different methods for defining sarcopenia: An aspect of cardiometabolic risk

(2017) Tae Nyun Kim et al.   Scientific Reports

A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes

(2016) Hung-Tsung Wu et al.   DIABETOLOGIA

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

(2016) Luca Valenti et al.   LIVER INTERNATIONAL

Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults

(2016) Joon Ho Moon et al.   PLoS One

Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population

(2016) Ge Meng et al.   Scientific Reports

Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia

(2016) Kyoung Min Kim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)

(2015) Yong-ho Lee et al.   JOURNAL OF HEPATOLOGY

Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study

(2015) Darryl P Leong et al.   LANCET

Criteria for Clinically Relevant Weakness and Low Lean Mass and Their Longitudinal Association With Incident Mobility Impairment and Mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project

(2014) Robert R. McLean et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study

(2013) Ho Cheol Hong et al.   HEPATOLOGY

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)

(2010) S. Lim et al.   DIABETES CARE

Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III

(2010) Preethi Srikanthan et al.   PLoS One

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

(2009) Anna Kotronen et al.   GASTROENTEROLOGY

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

(2008) S A Harrison et al.   GUT

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

(2008) Herbert Tilg et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM